HemaSphere
(Jun 2022)
P781: CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH LR-MDS REINITIATING ESAS FOLLOWING PREVIOUS ESA TREATMENT
- G. Garcia-Manero,
- R. K. Matsuno,
- A. McBride,
- T. D. Brown,
- D. Idryo,
- R. Broome,
- A. Herriman,
- T. Johnson,
- K. Wilkinson,
- S. Walters,
- A. Schrag,
- C. Johanson,
- M. Izano,
- S. Mukherjee
Affiliations
- G. Garcia-Manero
- 1 MD Anderson Cancer Center, Houston
- R. K. Matsuno
- 2 Syapse, San Francisco
- A. McBride
- 3 Bristol Myers Squibb, Princeton
- T. D. Brown
- 2 Syapse, San Francisco
- D. Idryo
- 2 Syapse, San Francisco
- R. Broome
- 2 Syapse, San Francisco
- A. Herriman
- 2 Syapse, San Francisco
- T. Johnson
- 2 Syapse, San Francisco
- K. Wilkinson
- 2 Syapse, San Francisco
- S. Walters
- 2 Syapse, San Francisco
- A. Schrag
- 2 Syapse, San Francisco
- C. Johanson
- 2 Syapse, San Francisco
- M. Izano
- 2 Syapse, San Francisco
- S. Mukherjee
- 4 Cleveland Clinic, Cleveland, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000846008.60144.6a
- Journal volume & issue
-
Vol. 6
pp.
676
– 677
WeChat QR code